Error: Could not add to watchlist. X
+ Watchlist

ArQule Inc

AQL:GR
Frankfurt
1.40
EUR
0.05
3.78%
As of 1:09 PM EDT 4/29/2016
Open
1.48
Day Range
1.35 - 1.48
Volume
0
Previous Close
1.46
52Wk Range
1.18 - 2.41
1 Yr Return
-23.40%
Open
1.48
Day Range
1.35 - 1.48
Volume
0
Previous Close
1.46
52Wk Range
1.18 - 2.41
1 Yr Return
-23.40%
YTD Return
-27.37%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-
Market Cap (m EUR)
99.559
Shares Outstanding (m)
71.063
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
ArQule Inc. develops cancer therapeutics based on its proprietary Activated Checkpoint Therapy platform. The Company's platform is designed to produce small molecule compounds that selectively kill cancer cells while leaving normal cells unharmed. ArQule's products are intended to be effective against multiple types of cancer.
Address
19 Presidential Way
Woburn, MA 01801-5140
United States
Phone
1-781-994-0300
Show More